Clinical Trials Directory

Trials / Unknown

UnknownNCT04564924

To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI

To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease Compared to Healthy Volunteers With MRI

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Patients with chronic kidney disease (CKD) have a higher risk of fractures than those without. The purpose of this study is to develop a non-invasive Magnetic resonance imaging (MRI) method that can improve fracture risk prediction and provide early diagnosis for bone abnormalities in patients with CKD.

Detailed description

Chronic Kidney Disease-Mineral and Bone Disorder (MBD) is a common complication of chronic kidney disease (CKD), which may lead to defective mineralization, altered bone morphology, and/or bone turnover. Animal research found that bone changes occur even in the early stage of CKD , and with CKD progression, the patient may show symptoms such as bone pain, joint pain, bone deformation, and even spontaneous fractures. Despite significant advances in understanding bone disease in CKD, most clinical and biochemical targets used in clinical practice remain controversial, resulting in an undermanagement of bone fragility.Our ability to diagnose CKD-MBD and to initiate strategies that could prevent fractures remains limited by the lack of accurate and noninvasive diagnostic tools. The purpose of this study is to develop a non-invasive method that can improve fracture risk prediction and provide early diagnosis for bone abnormalities in patients with CKD.

Conditions

Interventions

TypeNameDescription
RADIATIONDXABone mineral density was examined in all cases and controls

Timeline

Start date
2020-09-02
Primary completion
2021-09-30
Completion
2022-01-30
First posted
2020-09-25
Last updated
2020-09-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04564924. Inclusion in this directory is not an endorsement.